Please check your internet connection and try again.
# HepaMerz (L-Ornithine L-Aspartate)
## Overview
HepaMerz is a combination of two amino acids, L-ornithine and L-aspartate, which are involved in the urea cycle and protein synthesis. It is used to treat hyperammonemia associated with liver dysfunction.
## Primary Indications
Treatment of overt hepatic encephalopathy and latent hepatic encephalopathy in patients with cirrhosis or other liver diseases.
## Adult Dosing
* **Hepatic Encephalopathy:**
* Oral: 3 to 6 grams three times daily.
* Intravenous (IV): 5 grams twice daily for up to 7 days, followed by oral therapy.
* Dose and frequency may be adjusted based on patient response and ammonia levels. Maximum daily oral dose is typically 18 grams.
## Pediatric Dosing
* Dosing for pediatric patients is not well-established and should be based on institutional protocols and expert consultation.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, as the drug's metabolism is primarily independent of liver and kidney function. However, severe hepatic impairment may necessitate closer monitoring.
## Contraindications
* Hypersensitivity to L-ornithine or L-aspartate.
* Severe kidney disease.
## Adverse Effects
* Gastrointestinal disturbances: Nausea, vomiting, abdominal pain, diarrhea.
* Rarely: Allergic reactions, dizziness, headache.
## Key Drug Interactions
* No significant drug interactions are well-documented.
## Monitoring
* Monitor ammonia levels.
* Assess for signs and symptoms of hepatic encephalopathy.
* Monitor for gastrointestinal adverse effects.
## Clinical Pearls
* HepaMerz works by promoting ammonia detoxification in the liver and brain.
* It is generally well-tolerated.
* Oral administration should be taken with meals to minimize gastrointestinal upset.
* IV administration requires slow infusion.
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and clinical guidelines before making any treatment decisions. Dosing may vary based on patient-specific factors and local protocols.
